Loading...
Cognitive and Cultural Factors That Affect General Vaccination and COVID-19 Vaccination Attitudes.
Journal Title
Vaccines
Readers/Advisors
Journal Title
Term and Year
Publication Date
2022-12-30
Book Title
Publication Volume
11
Publication Issue
1
Publication Begin
Publication End
Number of pages
Collections
Files
Loading...
Article
Adobe PDF, 1.05 MB
Loading...
Supplementary material
Adobe PDF, 261.11 KB
Research Projects
Organizational Units
Journal Issue
Abstract
The development of COVID-19 vaccines is a major scientific accomplishment that has armed communities worldwide with powerful epidemic control tools. Yet, COVID-19 vaccination efforts in the US have been marred by persistent vaccine hesitancy. We used survey methodology to explore the impact of different cognitive and cultural factors on the public's general vaccination attitudes, attitudes towards COVID-19 vaccines, and COVID-19 vaccination status. The factors include information literacy, science literacy, attitudes towards science, interpersonal trust, public health trust, political ideology, and religiosity. The analysis suggests that attitudes towards vaccination are influenced by a multitude of factors that operate in a complex manner. General vaccination attitude was most affected by attitudes towards science and public health trust and to a lesser degree by information literacy, science literacy, and religiosity. Attitudes towards COVID-19 vaccines were most affected by public health trust and to a lesser extent by general trust, ideology and attitudes towards science. Vaccination status was most influenced by public health trust. Possible mediating effects of correlated variables in the model need to be further explored. The study underscores the importance of understanding the relationship between public health trust, literacies, and sociocultural factors.
Citation
Keselman A, Arnott Smith C, Wilson AJ, Leroy G, Kaufman DR. Cognitive and Cultural Factors That Affect General Vaccination and COVID-19 Vaccination Attitudes. Vaccines (Basel). 2022 Dec 30;11(1):94. doi: 10.3390/vaccines11010094. PMID: 36679939; PMCID: PMC9865922.